Literature DB >> 16682807

Differential modulation of ovine fetal ACTH secretion by PGHS-1 and PGHS-2.

Sharon Reimsnider1, Charles E Wood.   

Abstract

BACKGROUND/AIMS: We have previously demonstrated that prostaglandin generation within the fetal brain augments or partially mediates fetal reflex responsiveness to hypotension. The present study was performed to test the relative roles of prostaglandin endoperoxide synthases-1 and -2 (PGHS-1 and 2, or COX-1 and 2) as potential mediators of this interaction.
METHODS: Chronically catheterized and instrumented fetal sheep were subjected to transient brachiocephalic occlusion (BCO) after intracerebroventricular injection of resveratrol (PGHS-1 or COX-1 inhibitor), nimesulide (PGHS-2 or COX-2 inhibitor), or vehicle.
RESULTS: BCO decreased arterial pressure perfusing the fetal brain and stimulated increases in systemic blood pressure and heart rate as well as in circulating concentrations of ACTH. Inhibition of PGHS-1 and PGHS-2 had differential effects on fetal ACTH secretion. Pre-BCO concentrations of plasma ACTH increased in response to nimesulide, while the fetal ACTH response to BCO was delayed by resveratrol. Prior to the BCO, nimesulide also increased fetal blood pressure and decreased fetal heart rate. The injections of resveratrol and nimesulide did not alter placental biosynthesis of prostaglandins and therefore acted within the fetal brain.
CONCLUSION: We conclude that prostaglandin generated in the fetal brain by the action of PGHS-1 augments fetal ACTH reflex responses to BCO but that, in contrast, the action of PGHS-2 is inhibitory to ACTH secretion. 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682807     DOI: 10.1159/000093177

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  8 in total

1.  Interaction of PGHS-2 and glutamatergic mechanisms controlling the ovine fetal hypothalamus-pituitary-adrenal axis.

Authors:  Nathan Knutson; Charles E Wood
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-05       Impact factor: 3.619

2.  Up-regulation of the fetal baboon hypothalamo-pituitary-adrenal axis in intrauterine growth restriction: coincidence with hypothalamic glucocorticoid receptor insensitivity and leptin receptor down-regulation.

Authors:  Cun Li; Emma Ramahi; Mark J Nijland; Jaeyhek Choi; Dean A Myers; Peter W Nathanielsz; Thomas J McDonald
Journal:  Endocrinology       Date:  2013-04-26       Impact factor: 4.736

3.  Ketamine inhibits fetal ACTH responses to cerebral hypoperfusion.

Authors:  Melanie J Powers; Charles E Wood
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-12-07       Impact factor: 3.619

4.  Blockade of PGHS-2 inhibits the hypothalamus-pituitary-adrenal axis response to cerebral hypoperfusion in the sheep fetus.

Authors:  Charles E Wood; Melanie Powers Fraites; Maureen Keller-Wood
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-18       Impact factor: 3.619

5.  Inhibition of brain prostaglandin endoperoxide synthase-2 prevents the preparturient increase in fetal adrenocorticotropin secretion in the sheep fetus.

Authors:  Jason Gersting; Christine E Schaub; Maureen Keller-Wood; Charles E Wood
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

6.  Development of prostaglandin endoperoxide synthase expression in the ovine fetal central nervous system and pituitary.

Authors:  Jason A Gersting; Christine E Schaub; Charles E Wood
Journal:  Gene Expr Patterns       Date:  2009-08-23       Impact factor: 1.224

7.  Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation by inflammatory stimuli.

Authors:  Borja García-Bueno; Jordi Serrats; Paul E Sawchenko
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

8.  Blockade of estrogen receptors decreases CNS and pituitary prostaglandin synthase expression in fetal sheep.

Authors:  Christine E Schaub; Maureen Keller-Wood; Charles E Wood
Journal:  Neuroendocrinology       Date:  2007-10-09       Impact factor: 4.914

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.